Intimation of Receipt of Request for Reclassifiaction of the Promoter in accordance with Regulation 31A of the Securities and Exchange Board of India (Listing Obligations and Disclosure ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bacil Pharma has received requests from nine promoter/promoter group members to be reclassified as public shareholders under SEBI Regulation 31A. The applicants collectively hold only 11,500 equity shares (~0.085% of paid-up capital), with most holding zero shares. Only Gulecha Investment & Trading Co (10,800 shares, 0.08%) and two others hold any meaningful quantity, while the rest hold either 500, 200, or zero shares. Each applicant confirmed they have no control over company affairs, are not on the board, and are not willful defaulters or fugitive offenders. The reclassification is subject to approval from the Board, shareholders, and BSE.
This is largely a housekeeping change with no impact on actual ownership or voting power since the total shares involved are negligible (~0.085%). No share price impact expected; shareholders should watch for the board's approval and the subsequent shareholder vote.